Cardiology Headline News

Bariatric surgery for weight loss was associated with improvements in blood pressure and antihypertensive use among patients with obesity compared with medical therapy and/or lifestyle management, a speaker reported.

Pulmonary vein isolation was associated with genuine improvements in patients with atrial fibrillation at 6 months that cannot be attributed to a placebo effect, researchers reported at the European Society of Cardiology Congress.

The COVID-19 pandemic had a great impact on the health care system and the well-being of health care professionals, the effects of which are still felt today.

A bedside cardiac troponin test could reduce the time patients with ACS spend in the ED by nearly 45 minutes, with the availability of a doctor to assess the situation and move them to the cardiac ward, a speaker reported.

Edoxaban monotherapy for patients with atrial fibrillation and stable coronary disease reduced risk for adverse clinical events, mainly driven by lower bleeding risk, compared with dual antiplatelet therapy, a speaker reported.

Exposure to higher amounts of some types of per- and polyfluoroalkyl substances during pregnancy may lead to long-term increases in body weight, waist circumference and fat mass, according to new findings.

Black and white women have similar risk for preterm birth and preeclampsia when accounting for a wide range of social determinants of health, particularly socioeconomic factors, researchers reported.

When presented with four unlabeled treatment profiles showing five treatment attributes, 96% of patients with pulmonary arterial hypertension chose a single-tablet vs. a multi-tablet combination therapy, according to a poster.

An AI decision support tool embedded in routine care did not meaningfully improve outcomes for patients presenting to the ED with myocardial injury, but showed signs of benefit in an all-comer cohort, a speaker reported.

The Cardiometabolic Health Congress announced that Peter Libby, MD, one of the foremost authorities in atherosclerosis, will deliver the keynote address at its upcoming 19th annual conference.